Pharmacytimes: Condition Center: Atrial Fibrillation Atrial Fibrillation en-us Wed, 18 Jan 2017 10:12:12 UTC Wed, 18 Jan 2017 10:12:12 UTC Warfarin Nonadherence: What Factors Lead Patients with Afib to Discontinue? Patients with atrial fibrillation (AF) frequently discontinue their warfarin therapy, and a recently-published study offers insight into factors that may contribute to nonadherence.<br /> &nbsp; 9:45 AM, Thu January 12, 2017 Black Patients Face Greater Risk for Poor Afib Outcomes Black patients with atrial fibrillation are more likely to experience stroke, heart failure, and coronary heart disease than their white counterparts. 10:45 PM, Wed June 29, 2016 5 Medication Classes That Can Interact with Warfarin Warfarin can reportedly interact with more than 100 different medications from various classes. 8:40 AM, Wed March 30, 2016 What Do Afib Patients Know About Stroke? More than 3 million individuals in the United States have atrial fibrillation, and 1 in 4 Americans will develop the condition during his or her lifetime. 9:02 PM, Thu February 25, 2016 11 Afib Risk Factors Pharmacists Should Know Atrial fibrillation can be a tricky condition because patients may not know that they have it, as they may not exhibit any symptoms. 6:00 AM, Tue December 29, 2015 Direct Oral Anticoagulants for Afib: Peaks, Troughs, and Risks Most clinicians deem treatment response variability among direct oral anticoagulants—which include direct thrombin inhibitors and factor Xa inhibitors—clinically insignificant. 8:00 PM, Mon December 21, 2015 Anticoagulant Risk-Benefit Analysis for Traveling Afib Patients With the increase in the number of patients diagnosed with atrial fibrillation or needing stroke prevention treatment, roughly 3 million Americans currently take warfarin, while a lesser number takes direct oral agents. 11:09 PM, Mon December 7, 2015 How Pharmacists Can Counsel Overweight Afib Patients Losing weight can help decrease the recurrence of atrial fibrillation in overweight patients. 9:30 PM, Tue November 24, 2015 Afib Patients Given Novel Oral Anticoagulant See Shorter Hospital Stays Although warfarin is time-tested, the use of novel oral anticoagulants are a topic of interest to improve health outcomes in patients with non-valvular atrial fibrillation. 9:00 PM, Wed November 18, 2015 Afib Treatment Benefits from Patient Self-Management Patient self-management is an emerging anticoagulation delivery model that capitalizes on patients' willingness for in-depth warfarin education to help treat their atrial fibrillation. 10:00 PM, Tue November 10, 2015 Oral Anticoagulants for Afib: Which Decision Aids Work Best? Health care providers walk a tightrope when they employ oral anticoagulants in the treatment of atrial fibrillation. 11:00 PM, Mon October 26, 2015 Weekend Admission Doesn't Affect Afib Care Contrary to the findings of a previous study, patients with atrial fibrillation who are admitted to the hospital on the weekend face no greater risks than those admitted on a weekday. 8:00 AM, Thu October 22, 2015 Afib and Heart Failure: A Concomitant Conundrum Patients with concomitant atrial fibrillation (AF) and heart failure (HF) face worse symptoms, poorer prognoses, and different treatment responses than those with either condition alone. 8:00 AM, Sun October 11, 2015 What Promotes Dementia in Atrial Fibrillation Patients? Why are anticoagulated atrial fibrillation patients at higher risk of developing dementia? 8:00 AM, Tue September 29, 2015 Gout Means Greater Risk for Atrial Fibrillation Gout patients may be at greater risk for atrial fibrillation. 9:00 PM, Tue September 8, 2015 Half of Atrial Fibrillation Patients Discontinue Warfarin More than half of atrial fibrillation patients discontinue or interrupt warfarin therapy within 1 year of starting treatment. 10:00 PM, Sat August 29, 2015 Cardiac Clot Formation Unique in Atrial Fibrillation-Related Stroke Approximately 1 in 4 individuals will develop atrial fibrillation. Most disconcerting is their potential for hemorrhagic and ischemic stroke, as this risk increases up to 5-fold in AF patients. 9:00 PM, Mon August 24, 2015 How Community Pharmacists Can Screen for Atrial Fibrillation When a screening program is proposed, policymakers have some questions: does screening improve detection of the target diagnosis; is systematic screening better than opportunistic identification? 10:00 PM, Mon August 10, 2015 NOAC Prescriptions: What Pharmacists Need to Know Non-vitamin K antagonist oral anticoagulants are increasingly being prescribed to prevent and treat venous thromboembolism and avert stroke in patients with atrial fibrillation. 12:00 AM, Thu July 23, 2015 Bridging Raises Bleeding Risk in Atrial Fibrillation Patients on Warfarin A practice-changing study suggests bridging anticoagulation does more harm than good in atrial fibrillation (AF) patients treated with warfarin. 1:42 AM, Mon June 29, 2015